Study Identifies Links Between TMEM175, SCARB2, and CTSB Genes and Parkinson’s Disease Risk

A recent study published in *npj Parkinson’s Disease* has identified significant links between three specific genes—TMEM175, SCARB2, and CTSB—and the risk of developing Parkinson’s disease (PD). Researchers analyzed data from diverse populations to explore how these genes may influence the onset and progression of the neurodegenerative disorder. The findings provide new insights into the molecular and genetic factors associated with Parkinson’s disease.

The study examined genetic variations in TMEM175, SCARB2, and CTSB across multiple population groups. Researchers found evidence suggesting that these genes play a role in pathways connected to Parkinson’s disease development. By investigating their associations with PD risk, the study sheds light on potential mechanisms underlying the disease. The research highlights the importance of understanding genetic contributions to Parkinson’s disease on a global scale and offers a foundation for further exploration into targeted interventions or treatments.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: December 2, 2025

Related posts:

**New Studies Advance Parkinson’s Cell Therapy Development, Providing Insights for Future Research** Sino Biopharmaceutical to Acquire LaNova Medicines in $951 Million Deal Focused on PD-1xVEGF Cancer Therapies Study Explores Methods to Enhance Rooting Success and Nutrient Uptake in Hylocereus costaricensis Cultivation EGFR Activation Linked to Enhanced YAP Signaling in Diabetic Retinal Fibrosis Study by Zhang et al

Author

GOAI